429 related articles for article (PubMed ID: 6427267)
1. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
Borges JL; Blizzard RM; Evans WS; Furlanetto R; Rogol AD; Kaiser DL; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
[TBL] [Abstract][Full Text] [Related]
2. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.
Borges JL; Blizzard RM; Gelato MC; Furlanetto R; Rogol AD; Evans WS; Vance ML; Kaiser DL; MacLeod RM; Merriam GR; Loriaux DL; Spiess J; Rivier J; Vale W; Thorner MO
Lancet; 1983 Jul; 2(8342):119-24. PubMed ID: 6134978
[TBL] [Abstract][Full Text] [Related]
3. Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.
Evans WS; Borges JL; Vance ML; Kaiser DL; Rogol AD; Furlanetto R; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1984 Nov; 59(5):1006-10. PubMed ID: 6434583
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
Takano K; Hizuka N; Shizume K; Honda N; Ling NC
Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
[TBL] [Abstract][Full Text] [Related]
5. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
6. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
[TBL] [Abstract][Full Text] [Related]
7. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274
[TBL] [Abstract][Full Text] [Related]
8. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men.
Evans WS; Vance ML; Kaiser DL; Sellers RP; Borges JL; Downs TR; Frohman LA; Rivier J; Vale W; Thorner MO
J Clin Endocrinol Metab; 1985 Nov; 61(5):846-50. PubMed ID: 3930551
[TBL] [Abstract][Full Text] [Related]
10. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
Takano K; Hizuka N; Shizume K; Asakawa K; Miyakawa M; Hirose N; Shibasaki T; Ling NC
J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and somatomedin-C response to synthetic human pancreatic tumor GH-releasing factor in hypopituitary and constitutionally short children.
Minuto F; Barreca A; Del Monte P; Mauri R; Resentini M; Fortini P; Morabito M; Giordano G
J Endocrinol Invest; 1986 Dec; 9(6):447-52. PubMed ID: 3106458
[TBL] [Abstract][Full Text] [Related]
12. Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men.
Evans WS; Borges JL; Kaiser DL; Vance ML; Sellers RP; MacLeod RM; Vale W; Rivier J; Thorner MO
J Clin Endocrinol Metab; 1983 Nov; 57(5):1081-3. PubMed ID: 6413525
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH.
Borges JL; Uskavitch DR; Kaiser DL; Cronin MJ; Evans WS; Thorner MO
Endocrinology; 1983 Oct; 113(4):1519-21. PubMed ID: 6413195
[TBL] [Abstract][Full Text] [Related]
15. Human pancreatic tumor GH-releasing factor.
Thorner MO; Evans WS; Vance M; Borges JL; Blizzard RM; Rogol AD; MacLeod RM; Cronin MJ; Frohman LA; Thominet JL
Acta Neurochir (Wien); 1985; 75(1-4):72-80. PubMed ID: 2986423
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
Rogol AD; Blizzard RM; Johanson AJ; Furlanetto RW; Evans WS; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
[TBL] [Abstract][Full Text] [Related]
17. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
[TBL] [Abstract][Full Text] [Related]
18. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
[TBL] [Abstract][Full Text] [Related]
19. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
Webb CB; Vance ML; Thorner MO; Perisutti G; Thominet J; Rivier J; Vale W; Frohman LA
J Clin Invest; 1984 Jul; 74(1):96-103. PubMed ID: 6429198
[TBL] [Abstract][Full Text] [Related]
20. [The effect of synthetic human pancreatic growth hormone-releasing factor (hpGRF-44) on serum growth hormone response in normal and obese subjects].
Shimizu T; Inoue K
Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):82-96. PubMed ID: 3084310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
